JAMA Otolaryngology—Head & Neck Surgery

JAMA Otolaryngology—Head & Neck Surgery JAMA Otolaryngology is a member of the JAMA Network, a consortium of peer-reviewed publications.

💬 Editorial by JAMA Otolaryngology—Head & Neck Surgery Editor in Chief Jay F. Piccirillo, MD: JAMA Otolaryngology–Head &...
02/08/2026

💬 Editorial by JAMA Otolaryngology—Head & Neck Surgery Editor in Chief Jay F. Piccirillo, MD: JAMA Otolaryngology–Head & Neck Surgery upholds transparency, rigorous peer review, and conflict-of-interest management to ensure research credibility.

https://bit.ly/3O0QkHj

Narrative review: Large language models ( ) can structure clinical notes, automate phenotyping, and augment decision sup...
02/07/2026

Narrative review: Large language models ( ) can structure clinical notes, automate phenotyping, and augment decision support in otolaryngology but require validation beyond feasibility and secure, open-source deployment.

https://bit.ly/4adZdEC

Systematic review and meta-analysis: Thyroidectomy in adults ≥65 years showed small absolute increases in nerve injury, ...
02/06/2026

Systematic review and meta-analysis: Thyroidectomy in adults ≥65 years showed small absolute increases in nerve injury, hematoma, and mortality, but similar rates of hypocalcemia and wound complications compared to younger adults.

https://bit.ly/4kr7Vo0

In patients with   who received hypoglossal nerve stimulation ( ), smaller necks, BMI
02/05/2026

In patients with who received hypoglossal nerve stimulation ( ), smaller necks, BMI

💬 Editorial: JAMA Otolaryngology–Head & Neck Surgery upholds transparency, rigorous peer review, and conflict-of-interes...
02/05/2026

💬 Editorial: JAMA Otolaryngology–Head & Neck Surgery upholds transparency, rigorous peer review, and conflict-of-interest management to ensure research credibility.

https://bit.ly/3NW7lSV

While balloon sinuplasty was performed in just 2.7% of newly diagnosed Medicare patients with chronic or recurrent acute...
02/03/2026

While balloon sinuplasty was performed in just 2.7% of newly diagnosed Medicare patients with chronic or recurrent acute rhinosinusitis, 1.5% of otolaryngologists performed nearly half of all procedures. https://ja.ma/4qPrb0B

This case report describes a patient who presented with isolated left-sided conductive hearing loss. https://ja.ma/3NNBR...
02/03/2026

This case report describes a patient who presented with isolated left-sided conductive hearing loss. https://ja.ma/3NNBRhT

02/02/2026

JAMA Cardiology marks its 10th anniversary with a leadership transition that builds on a decade of extraordinary growth.

Today we welcome Barbara Casadei, MD, DPhil, from the National Heart and Lung Institute, Imperial College London, as Editor in Chief. An internationally recognized clinician‑scientist, Dr Casadei brings extensive experience in global cardiovascular research.

In her inaugural Editorial, Dr Casadei outlines a vision focused on:

📌 Make JAMA Cardiology a global meeting place, fostering engagement and contributions from a diverse, international community. The journal will disseminate trustworthy, evidence-based information, especially on managing increasingly older and complex patients, while addressing the challenges posed by misinformation and pressures on the profession.

📌 Encourage innovative scholarship that develops new ways to implement preventive measures for cardiovascular disease at scale, learning from countries that have creatively overcome cultural, financial, or geographic obstacles

📌 Demystify emerging technologies, particularly artificial intelligence (AI), and make them accessible and familiar to the cardiovascular community and narrow the divide between clinicians and data/computer scientists.

“We want to inspire and support the next generation of cardiovascular investigators and hold ourselves responsible for communicating the importance of conducting research that has the potential to improve cardiovascular health and, thus, the quality of life of hundreds of millions of people worldwide,” she writes.

🔗 Read the Editorial: https://ja.ma/3NQN0hQ
📬 Subscribe for updates: https://ja.ma/4a9GZUX
💡 Submit high impact work: https://ja.ma/4rkktzA

Intratumoral NBTXR3 followed by   showed feasibility and promising response rates in cisplatin- or cetuximab-ineligible ...
02/02/2026

Intratumoral NBTXR3 followed by showed feasibility and promising response rates in cisplatin- or cetuximab-ineligible patients with locally advanced .

https://ja.ma/3MfAQyy

Systematic review and network meta-analysis: Diltiazem, esmolol, dexmedetomidine, labetalol, and clonidine reduced bleed...
02/01/2026

Systematic review and network meta-analysis: Diltiazem, esmolol, dexmedetomidine, labetalol, and clonidine reduced bleeding during , with comparable safety and flexibility for individualized management. https://ja.ma/4a7snFs

Intratumoral NBTXR3 followed by   showed feasibility and promising response rates in cisplatin- or cetuximab-ineligible ...
01/31/2026

Intratumoral NBTXR3 followed by showed feasibility and promising response rates in cisplatin- or cetuximab-ineligible patients with locally advanced .

https://ja.ma/4r0Euvl

Among patients with head and neck  , sentinel lymph node biopsy identified occult nodal disease in more than half of cas...
01/31/2026

Among patients with head and neck , sentinel lymph node biopsy identified occult nodal disease in more than half of cases but showed reduced accuracy compared to other sites.

https://ja.ma/45CrhQP

Address

330 N Wabash Avenue
Chicago, IL
60611

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+13126707827

Alerts

Be the first to know and let us send you an email when JAMA Otolaryngology—Head & Neck Surgery posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram